264 related articles for article (PubMed ID: 2292657)
21. [The correlation between endogenous TgAb and experimental Tg values in patients with differentiated thyroid carcinomas].
Tang GS; Xu J; Yu Y; Pan MZ; Wang JR; Yuan LP; Jiang T; Huang F; Jing CL
Sichuan Da Xue Xue Bao Yi Xue Ban; 2011 Nov; 42(6):856-60. PubMed ID: 22332559
[TBL] [Abstract][Full Text] [Related]
22. Clinical Applicability of Low Levels of Thyroglobulin Autoantibodies as Cutoff Point for Thyroglobulin Autoantibody Positivity.
Dekker BL; van der Horst-Schrivers ANA; Sluiter WJ; Brouwers AH; Lentjes EGWM; Heijboer AC; Muller Kobold AC; Links TP
Thyroid; 2019 Jan; 29(1):71-78. PubMed ID: 30351209
[TBL] [Abstract][Full Text] [Related]
23. Thyroglobulin antibodies in serum of patients with differentiated thyroid cancer: relationship between epitope specificities and thyroglobulin recovery.
Okosieme OE; Evans C; Moss L; Parkes AB; Premawardhana LD; Lazarus JH
Clin Chem; 2005 Apr; 51(4):729-34. PubMed ID: 15695326
[TBL] [Abstract][Full Text] [Related]
24. Serum thyroglobulin autoantibodies: prevalence, influence on serum thyroglobulin measurement, and prognostic significance in patients with differentiated thyroid carcinoma.
Spencer CA; Takeuchi M; Kazarosyan M; Wang CC; Guttler RB; Singer PA; Fatemi S; LoPresti JS; Nicoloff JT
J Clin Endocrinol Metab; 1998 Apr; 83(4):1121-7. PubMed ID: 9543128
[TBL] [Abstract][Full Text] [Related]
25. Comparison of the influence of thyroglobulin antibodies on serum thyroglobulin values from two different immunoassays in post surgical differentiated thyroid carcinoma patients.
Stanojevic M; Savin S; Cvejic D; Djukic A; Jeremic M; Zivancević Simonovic S
J Clin Lab Anal; 2009; 23(5):341-6. PubMed ID: 19774624
[TBL] [Abstract][Full Text] [Related]
26. The diagnostic value for differentiated thyroid carcinoma metastases of thyroglobulin (Tg) measurement in washout fluid from fine-needle aspiration biopsy of neck lymph nodes is maintained in the presence of circulating anti-Tg antibodies.
Boi F; Baghino G; Atzeni F; Lai ML; Faa G; Mariotti S
J Clin Endocrinol Metab; 2006 Apr; 91(4):1364-9. PubMed ID: 16434461
[TBL] [Abstract][Full Text] [Related]
27. [Influence of endogenous TgAb upon serum Tg measurement results and Tg positive rate in patients with differentiated thyroid carcinoma].
Zhang W; Deng H; Pan M; Huang R; Tang G
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2013 Aug; 30(4):803-7. PubMed ID: 24059060
[TBL] [Abstract][Full Text] [Related]
28. Changing Trend of Thyroglobulin Antibodies in Patients With Differentiated Thyroid Cancer Treated With Total Thyroidectomy Without
Matrone A; Latrofa F; Torregrossa L; Piaggi P; Gambale C; Faranda A; Ricci D; Agate L; Molinaro E; Basolo F; Vitti P; Elisei R
Thyroid; 2018 Jul; 28(7):871-879. PubMed ID: 29860933
[TBL] [Abstract][Full Text] [Related]
29. Sequential changes of serum antithyroglobulin antibody levels are a good predictor of disease activity in thyroglobulin-negative patients with papillary thyroid carcinoma.
Hsieh CJ; Wang PW
Thyroid; 2014 Mar; 24(3):488-93. PubMed ID: 23971786
[TBL] [Abstract][Full Text] [Related]
30. Comparison of Antithyroglobulin Antibody Concentrations Before and After Ablation with 131I as a Predictor of Structural Disease in Differentiated Thyroid Carcinoma Patients with Undetectable Basal Thyroglobulin and Negative Neck Ultrasonography.
Rosario PW; Carvalho M; Mourão GF; Calsolari MR
Thyroid; 2016 Apr; 26(4):525-31. PubMed ID: 26831821
[TBL] [Abstract][Full Text] [Related]
31. The follow-up of patients with differentiated thyroid cancer and undetectable thyroglobulin (Tg) and Tg antibodies during ablation.
Phan HT; Jager PL; van der Wal JE; Sluiter WJ; Plukker JT; Dierckx RA; Wolffenbuttel BH; Links TP
Eur J Endocrinol; 2008 Jan; 158(1):77-83. PubMed ID: 18166820
[TBL] [Abstract][Full Text] [Related]
32. Correlation of 18F-FDG PET/CT findings with histopathological results in differentiated thyroid cancer patients who have increased thyroglobulin or antithyroglobulin antibody levels and negative 131I whole-body scan results.
Ozkan E; Aras G; Kucuk NO
Clin Nucl Med; 2013 May; 38(5):326-31. PubMed ID: 23486319
[TBL] [Abstract][Full Text] [Related]
33. Lymphocytic thyroiditis on histology correlates with serum thyroglobulin autoantibodies in patients with papillary thyroid carcinoma: impact on detection of serum thyroglobulin.
Latrofa F; Ricci D; Montanelli L; Rocchi R; Piaggi P; Sisti E; Grasso L; Basolo F; Ugolini C; Pinchera A; Vitti P
J Clin Endocrinol Metab; 2012 Jul; 97(7):2380-7. PubMed ID: 22539585
[TBL] [Abstract][Full Text] [Related]
34. Change of serum antithyroglobulin antibody levels is useful for prediction of clinical recurrence in thyroglobulin-negative patients with differentiated thyroid carcinoma.
Kim WG; Yoon JH; Kim WB; Kim TY; Kim EY; Kim JM; Ryu JS; Gong G; Hong SJ; Shong YK
J Clin Endocrinol Metab; 2008 Dec; 93(12):4683-9. PubMed ID: 18812478
[TBL] [Abstract][Full Text] [Related]
35. Quantitative reverse transcription-polymerase chain reaction of circulating thyroglobulin messenger ribonucleic acid for monitoring patients with thyroid carcinoma.
Ringel MD; Balducci-Silano PL; Anderson JS; Spencer CA; Silverman J; Sparling YH; Francis GL; Burman KD; Wartofsky L; Ladenson PW; Levine MA; Tuttle RM
J Clin Endocrinol Metab; 1999 Nov; 84(11):4037-42. PubMed ID: 10566646
[TBL] [Abstract][Full Text] [Related]
36. Detecting Recurrence Following Lobectomy for Thyroid Cancer: Role of Thyroglobulin and Thyroglobulin Antibodies.
Ritter A; Mizrachi A; Bachar G; Vainer I; Shimon I; Hirsch D; Diker-Cohen T; Duskin-Bitan H; Robenshtok E
J Clin Endocrinol Metab; 2020 Jun; 105(6):. PubMed ID: 32219303
[TBL] [Abstract][Full Text] [Related]
37. Value of repeat stimulated thyroglobulin testing in patients with differentiated thyroid carcinoma considered to be free of disease in the first year after ablation.
Rosario PW; Furtado MS; Mineiro Filho AF; Lacerda RX; Calsolari MR
Thyroid; 2012 May; 22(5):482-6. PubMed ID: 22175271
[TBL] [Abstract][Full Text] [Related]
38. The role of 18F-FDG PET/CT in the follow-up of well-differentiated thyroid cancer with negative thyroglobulin but positive and/or elevated antithyroglobulin antibody.
Liu Y
Nucl Med Commun; 2016 Jun; 37(6):577-82. PubMed ID: 26813991
[TBL] [Abstract][Full Text] [Related]
39. Clinical review: Clinical utility of thyroglobulin antibody (TgAb) measurements for patients with differentiated thyroid cancers (DTC).
Spencer CA
J Clin Endocrinol Metab; 2011 Dec; 96(12):3615-27. PubMed ID: 21917876
[TBL] [Abstract][Full Text] [Related]
40. Measuring thyroglobulin in patients with thyroglobulin autoantibodies: evaluation of the clinical impact of BRAHMS Kryptor® Tg-minirecovery test in a large series of patients with differentiated thyroid carcinoma.
Giovanella L; Verburg FA; Trimboli P; Imperiali M; Keller F; Ceriani L
Clin Chem Lab Med; 2019 Jul; 57(8):1185-1191. PubMed ID: 30835250
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
